Menopausal Hot Flashes Market

Menopausal Hot Flashes - Global Market Outlook (2019-2027)

4.4 (41 reviews)
Published: July 2020 ID: SMRC19701
4.4 (41 reviews)
Published: July 2020 ID: SMRC19701

This report covers the impact of COVID-19 on this global market

According to Stratistics MRC, the Global Menopausal Hot Flashes Market is accounted for $10.26 billion in 2019 and is expected to reach $18.99 billion by 2027 growing at a CAGR of 8.0% during the forecast period. Growing population of elderly women across the globe and technological advancement in the development of new drugs for the treatment are the major factors driving the market growth. However, availability of generic medicines is restraining the market growth.

Menopausal hot flashes are the symptoms of menopause. They refer to feelings of warmth occurring during menopause transition (that includes stages such as premenopause, perimenopause, and postmenopause). They cause redness of the skin (known as flushing) and excessive sweating. 

Based on distribution channel, the retail pharmacies segment is likely to have a huge demand as it is preferred by large number of consumers such as pharmaceutical stores, hospitals, drugs stores, and clinics. Factors such as the growing female population and growth in the number of retail outlets in developing and emerging countries such as China and India will fuel the demand for women’s health products. By geography, North America is going to have a lucrative growth during the forecast period due to growing baby boomer population, high health care expenditure, and large number of prescriptions of hormonal as well as non-hormonal treatment products.

Some of the key players profiled in the Menopausal Hot Flashes Market include Allergan plc, GlaxoSmithKline plc, Hisamitsu Pharmaceutical Co Inc, Merck & Co Inc, Mylan N.V, Novartis AG, Novo Nordisk A/S, Pfizer Inc, Teva Pharmaceutical Industries Ltd and TherapeuticsMD Inc.

Types Covered:
• Oral Liquid
• Pill

Treatment Types Covered:
• Alternative Treatment
• Hormonal Treatment
• Non-Hormonal Treatment   

Pipeline Analysis Covered:
• Phase III Drugs
• Phase I and II Drugs   

Distribution Channels Covered:
• Hospital Pharmacies
• Online Pharmacies
• Retail Pharmacies

Applications Covered:
• 51-55 Year Old Woman
• 46-50 Year Old Woman
• 40-45 Year Old Woman

Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan       
o China       
o India       
o Australia 
o New Zealand
o South Korea
o Rest of Asia Pacific   
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o Qatar
o South Africa
o Rest of Middle East & Africa

What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2018, 2019, 2020, 2024 and 2027
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic analysis: Drivers and Constraints, Product/Technology Analysis, Porter’s five forces analysis, SWOT analysis, etc.
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Select License Type

Allows one person to have access to the ordered product.The ordered product cannot be distributed to anyone else.
Allows the ordered product to be shared among a maximum of 5 people within your organisation.
Allows the product to be shared among all employees of your organisation at one particular location.
Allows the product to be shared among all employees of your organisation regardless of their geographical location.


Assured Quality

Assured Quality

Best in class reports with high standard of research integrity

24X7 Research Support

24X7 Research Support

Continuous support to ensure the best customer experience.

Free Customization

Free Customization

Adding more values to your product of interest.

Safe and Secure Access

Safe & Secure Access

Providing a secured environment for all online transactions.

Trusted by 600+ Brands

Trusted by 600+ Brands

Serving the most reputed brands across the world.